logo

IPSC

Century Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.80 / 10
Netural

Fund flow analysis scores 7.6/10, indicating robust liquidity with positive trends in block, medium, and large flows, despite minor negative signals in small and extra-large categories. Analyst consensus remains Buy across all coverage providers, but the most recent action—Clear Street lowering the price target to $6.60—adds a note of caution. Together, the strong fund inflows and bullish analyst stance partially offset the weak technicals.

FundamentalSentiment(3.8)Technical
Fund Flow Rating
Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

0%

Buy

100%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-20
InstitutionPiper Sandler
Times predicted2
Historical Win Rate0.0%
What is the market sentiment for IPSC?
  • IPSC holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.80/10 (Netural).